186 related articles for article (PubMed ID: 14705024)
1. Docking studies and model development of tea polyphenol proteasome inhibitors: applications to rational drug design.
Smith DM; Daniel KG; Wang Z; Guida WC; Chan TH; Dou QP
Proteins; 2004 Jan; 54(1):58-70. PubMed ID: 14705024
[TBL] [Abstract][Full Text] [Related]
2. Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit.
Daniel KG; Landis-Piwowar KR; Chen D; Wan SB; Chan TH; Dou QP
Int J Mol Med; 2006 Oct; 18(4):625-32. PubMed ID: 16964415
[TBL] [Abstract][Full Text] [Related]
3. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.
Landis-Piwowar KR; Wan SB; Wiegand RA; Kuhn DJ; Chan TH; Dou QP
J Cell Physiol; 2007 Oct; 213(1):252-60. PubMed ID: 17477351
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.
Kazi A; Wang Z; Kumar N; Falsetti SC; Chan TH; Dou QP
Anticancer Res; 2004; 24(2B):943-54. PubMed ID: 15161048
[TBL] [Abstract][Full Text] [Related]
5. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitors.
Wan SB; Landis-Piwowar KR; Kuhn DJ; Chen D; Dou QP; Chan TH
Bioorg Med Chem; 2005 Mar; 13(6):2177-85. PubMed ID: 15727870
[TBL] [Abstract][Full Text] [Related]
7. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo.
Nam S; Smith DM; Dou QP
J Biol Chem; 2001 Apr; 276(16):13322-30. PubMed ID: 11278274
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies.
Navarro-Perán E; Cabezas-Herrera J; Hiner AN; Sadunishvili T; García-Cánovas F; Rodríguez-López JN
Biochemistry; 2005 May; 44(20):7512-25. PubMed ID: 15895994
[TBL] [Abstract][Full Text] [Related]
9. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
10. Role of green tea polyphenols in the inhibition of collagenolytic activity by collagenase.
Madhan B; Krishnamoorthy G; Rao JR; Nair BU
Int J Biol Macromol; 2007 Jun; 41(1):16-22. PubMed ID: 17207851
[TBL] [Abstract][Full Text] [Related]
11. Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor.
Kuhn DJ; Burns AC; Kazi A; Dou QP
Biochim Biophys Acta; 2004 Jun; 1682(1-3):1-10. PubMed ID: 15158750
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
Williamson MP; McCormick TG; Nance CL; Shearer WT
J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
[TBL] [Abstract][Full Text] [Related]
13. Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention.
Kazi A; Smith DM; Daniel K; Zhong S; Gupta P; Bosley ME; Dou QP
In Vivo; 2002; 16(6):397-403. PubMed ID: 12494882
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
Loidl G; Groll M; Musiol HJ; Ditzel L; Huber R; Moroder L
Chem Biol; 1999 Apr; 6(4):197-204. PubMed ID: 10099130
[TBL] [Abstract][Full Text] [Related]
15. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins.
Leone M; Zhai D; Sareth S; Kitada S; Reed JC; Pellecchia M
Cancer Res; 2003 Dec; 63(23):8118-21. PubMed ID: 14678963
[TBL] [Abstract][Full Text] [Related]
16. Study of the green tea polyphenols catechin-3-gallate (CG) and epicatechin-3-gallate (ECG) as proteasome inhibitors.
Wan SB; Chen D; Dou QP; Chan TH
Bioorg Med Chem; 2004 Jul; 12(13):3521-7. PubMed ID: 15186836
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs.
Landis-Piwowar KR; Kuhn DJ; Wan SB; Chen D; Chan TH; Dou QP
Int J Mol Med; 2005 Apr; 15(4):735-42. PubMed ID: 15754040
[TBL] [Abstract][Full Text] [Related]
18. Synthetic analogs of green tea polyphenols as proteasome inhibitors.
Smith DM; Wang Z; Kazi A; Li LH; Chan TH; Dou QP
Mol Med; 2002 Jul; 8(7):382-92. PubMed ID: 12393936
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site.
Miyata M; Sato T; Kugimiya M; Sho M; Nakamura T; Ikemizu S; Chirifu M; Mizuguchi M; Nabeshima Y; Suwa Y; Morioka H; Arimori T; Suico MA; Shuto T; Sako Y; Momohara M; Koga T; Morino-Koga S; Yamagata Y; Kai H
Biochemistry; 2010 Jul; 49(29):6104-14. PubMed ID: 20565072
[TBL] [Abstract][Full Text] [Related]
20. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
